• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Differential Responses to Rhinovirus and Influenza-associated Pulmonary Exacerbations in Patients with Cystic Fibrosis

tetano

Editor, Senior Moderator
Ann Am Thorac Soc. 2014 Mar 18. [Epub ahead of print]
Differential Responses to Rhinovirus and Influenza-associated Pulmonary Exacerbations in Patients with Cystic Fibrosis.
Ramirez IA1, Caverly LL, Kalikin LM, Goldsmith AM, Lewis TC, Burke DT, Lipuma JJ, Sajjan US, Hershenson MB.
Author information
Abstract

Rationale: The mechanism by which viruses cause exacerbations of chronic airways disease, and the capacity of cystic fibrosis (CF) patients to respond to viral infections, are not precisely known. Objectives: To determine the antiviral response to infection in patients with CF. Methods: Sputum and bronchoalveolar lavage fluid were collected from CF patients with respiratory exacerbation. Viruses were detected using a single-step multiplex polymerase chain reaction (PCR)-based assay and a multiplex PCR-ligase detection reaction assay. Gene expression of 84 antiviral response genes was measured using a focused quantitative PCR gene array. Measurements and Main Results: We examined 56 samples from 36 patients with respiratory exacerbation. Twenty-three samples tested virus-positive and 33 virus-negative. Five genes were upregulated at least 2-fold by viral infection (CXCL10, CXCL11, IL15, SUGT1, TLR8). When we compared exacerbations caused by rhinovirus (RV, n=12) and influenza (n=7) to virus-negative specimens, we found distinct patterns of antiviral gene expression. RV induced >2-fold expression of eight genes including CXCL10, CXCL11 and CCL5, genes encoding chemokines for mononuclear cells, as well as IFIH1, the gene encoding MDA-5, an RNA helicase recognizing RV double-stranded RNA. Influenza induced overexpression of 16 genes including CXCL8, IL1B and TNF, cytokines stimulating neutrophilic and systemic inflammation; MAP2K1, MAP3K7 and TBK1, kinases upstream of NF-κB activation; and MX1 and ISG15, interferon-stimulated genes involved in influenza resistance. Conclusions: We conclude that viral-induced exacerbations of CF are associated with immune responses tailored to specific infections. Influenza induced a more potent response consisting of inflammation and interferon-stimulated genes, whereas RV infection had a pronounced effect on chemokine expression. As far as we are aware, this study is the first to compare specific responses to different viruses in live patients with chronic airways disease.

PMID:
24641803
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24641803
 
Back
Top Bottom